Evaluating the Suitability and Potential Efficiency of Cannabis sativa Oil for Patients with Primary Burning Mouth Syndrome: A Prospective, Open-Label, Single-Arm Pilot Study

被引:9
|
作者
Gambino, Alessio [1 ]
Cabras, Marco [1 ]
Panagiotakos, Evangelos
Calvo, Federico [1 ]
Macciotta, Alessandra [2 ]
Cafaro, Adriana [1 ]
Suria, Marco [1 ]
Haddad, Giorgia El [1 ]
Broccoletti, Roberto [1 ]
Arduino, Paolo Giacomo [1 ]
机构
[1] Univ Turin, Dept Surg Sci, Oral Med Sect, Turin, Italy
[2] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
关键词
Tetrahydrocannabinol (THC); Oil; Open-Label; Burning Mouth Syndrome; Outcome; PAIN; CLASSIFICATION; MANAGEMENT; CLONAZEPAM; EFFICACY; SAFETY; BRAIN;
D O I
10.1093/pm/pnaa318
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. To evaluate the use of a Cannabis sativa oil in the management of patients diagnosed with primary burning mouth syndrome (BMS). Design. Prospective, open-label, single-arm pilot study. Setting. University hospital. Subjects. Seventeen patients with diagnosed BMS were included. Methods. Subjects were treated for 4weeks with a full cannabis plant extract, which was prepared from standardized plant material (cannabis flos) in specialized pharmacies by means of Romano-Hazekamp extraction and was diluted in oil (1g of cannabis in 10g of olive oil). The primary outcome was the change in pain intensity (assessed by the visual analog scale, Present Pain Intensity scale, McGill Pain Questionnaire, and Oral Health Impact Profiles) at the end of the protocol and during the succeeding 24 weeks; the neuropathic pain was also investigated with a specific interview questionnaire (DN4-interview [Douleur Neuropathique en 4 Questions]). Levels of anxiety and depression were considered as secondary outcomes, together with reported adverse events due to the specified treatment. Results. Subjects showed a statistically significant improvement over time in terms of a clinical remission of the oral symptoms. Levels of anxiety and depression also changed statistically, displaying a favorable improvement. No serious reactions were detailed. None of the patients had to stop the treatment due to adverse events. Conclusions. In this pilot evaluation, the C. sativa oil provided was effective and well tolerated in patients with primary BMS. Further bigger and properly defined randomized controlled trials, with different therapeutic approaches or placebo control, are needed, however.
引用
收藏
页码:142 / 151
页数:10
相关论文
共 50 条
  • [31] A three-month, open-label, single-arm trial evaluating the safety and pharmacokinetics of oral lithium in patients with chronic spinal cord injury
    Y W Wong
    S Tam
    K F So
    J Y H Chen
    W S Cheng
    K D K Luk
    S W Tang
    W Young
    Spinal Cord, 2011, 49 : 94 - 98
  • [32] Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study
    Neutel, Joel M.
    Giles, Thomas D.
    Punzi, Henry
    Weiss, Robert J.
    Li, Huiling
    Finck, Amy
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (12) : 915 - 920
  • [33] A three-month, open-label, single-arm trial evaluating the safety and pharmacokinetics of oral lithium in patients with chronic spinal cord injury
    Wong, Y. W.
    Tam, S.
    So, K. F.
    Chen, J. Y. H.
    Cheng, W. S.
    Luk, K. D. K.
    Tang, S. W.
    Young, W.
    SPINAL CORD, 2011, 49 (01) : 94 - 98
  • [34] A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia
    Hamauchi, Satoshi
    Furuse, Junji
    Takano, Toshimi
    Munemoto, Yoshinori
    Furuya, Ken
    Baba, Hideo
    Takeuchi, Manabu
    Choda, Yasuhiro
    Higashiguchi, Takashi
    Naito, Tateaki
    Muro, Kei
    Takayama, Koichi
    Oyama, Shusuke
    Takiguchi, Toru
    Komura, Naoyuki
    Tamura, Kazuo
    CANCER, 2019, 125 (23) : 4294 - 4302
  • [35] The Short-term Effect of Graded Motor Imagery on the Affective Components of Pain in Subjects with Chronic Shoulder Pain Syndrome: Open-Label Single-Arm Prospective Study
    Araya-Quintanilla, Felipe
    Gutierrez-Espinoza, Hector
    Jesus Munoz-Yanez, Maria
    Rubio-Oyarzun, David
    Cavero-Redondo, Ivan
    Martinez-Vizcaino, Vicente
    Alvarez-Bueno, Celia
    PAIN MEDICINE, 2020, 21 (10) : 2496 - 2501
  • [36] A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
    Lanfear, David E.
    Neaton, Kelsey R.
    Lu, Chen
    Liu, Yimeng
    Dent-Acosta, Ricardo E.
    CARDIOLOGY AND THERAPY, 2020, 9 (02) : 561 - 568
  • [37] A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
    David E. Lanfear
    Kelsey R. Neaton
    Chen Lu
    Yimeng Liu
    Ricardo E. Dent-Acosta
    Cardiology and Therapy, 2020, 9 : 561 - 568
  • [38] Effect of a Mindfulness-Based Intervention for Chronic Migraine and High Frequency Episodic Migraine in Adolescents: A Pilot Single-Arm Open-Label Study
    Grazzi, Licia
    Grignani, Eleonora
    Raggi, Alberto
    Rizzoli, Paul
    Guastafierro, Erika
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (22)
  • [39] Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study
    Tiede, Andreas
    Hart, Christina
    Knoebl, Paul
    Greil, Richard
    Oldenburg, Johannes
    Sachs, Ulrich J.
    Miesbach, Wolfgang
    Pfrepper, Christian
    Trautmann-Grill, Karolin
    Holstein, Katharina
    Pilch, Jan
    Moehnle, Patrick
    Schindler, Christoph
    Weigt, Carmen
    Schipp, Dorothea
    May, Marcus
    Dobbelstein, Christiane
    Pelzer, Fabius J.
    Werwitzke, Sonja
    Klamroth, Robert
    LANCET HAEMATOLOGY, 2023, 10 (11): : E913 - E921
  • [40] Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
    Chang, Gee-Chen
    Tsai, Chun-Ming
    Hsia, Te-Chun
    Yang, Chih-Hsin
    Abdulnabi, Radhi
    Blair, Julie M.
    Linn, Carlos
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (09) : 518 - 526